
Earn up to a maximum of 10.25 AMA PRA Category 1 Credits™, or 10.25 AAPA Category 1 CME credits, or 10.25 ANCC contact hours!
SOCIETY ENDORSEMENT


COURSE DIRECTORS

Mack Mitchell, MD
Vice President for Medical Affairs
University of Texas Southwestern
Medical Center
Dallas, Texas

Lawrence Schiller, MD
Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas
FACULTY

Sumeet Asrani, MD
Baylor University
Medical Center
Dallas, Texas

Brooks Cash ,MD
Baylor Scott & White Health
Dallas, Texas

Mack Mitchell, MD
University of Texas Southwestern Medical Center
Dallas, Texas

David Rubin, MD
University of Chicago
Chicago, Illinois

Lisa VanWagner, MD
University of Texas Southwestern Medical Center
Dallas, Texas

Kimberly Brown, MD
Henry Ford
Hospital
Detroit, Michigan

Harish Gagneja, MD
Austin Gastro
Austin, Texas

Jan Petrasek, MD
UT Health
San Antonio
San Antonio, Texas

Lawrence Schiller, MD
Baylor University
Medical Center
Dallas, Texas

John Vierling, MD
Baylor College
of Medicine
Houston, Texas

Freddy Caldera, DO, PhD, MS
University of Wisconsin-Madison School of Medicine
Madison, Wisconsin

Paul Kwo, MD
Stanford University
Palo Alto, California

Siobhan Proksell, MD
University of Colorado School
of Medicine
Aurora, Colorado

Stuart Spechler, MD
Baylor University
Medical Center
Dallas, Texas

Sachin Wani, MD
Katy O and Paul M Rady Esophageal and Gastric Center of Excellence
Aurora, Colorado
AGENDA
Friday, May 15, 2026
11:00 AM
Lunch and Registration
11:30 AM - 12:15 PM
Tremfya for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Tauseef Ali, MD
Industry-Sponsored Event*
Sponsored by Johnson & Johnson
​​
12:15 PM - 12:45 PM
Break and Visit Exhibits*
12:45 PM - 1:00 PM
Program Overview
Session I
1:00 PM - 1:25 PM
Achalasia Versus EGJ Outflow Obstruction​
Stuart Spechler, MD
​
1:25 PM - 1:50 PM
Surveillance for Barrett’s Esophagus
Sachin Wani, MD
​​​​
1:50 PM - 2:15 PM
Management of Obesity in 2026​
2:15 PM - 2:30 PM
Q&A / Panel Discussion
2:30 PM – 2:45 PM
Break and Visit Exhibits*
Session II
​
2:45 PM - 3:10 PM
Reducing Alcohol Use in Patients with Steatotic Liver Disease
Jan Petrasek, MD
​
​​3:10 PM - 3:35 PM
Updates in Primary Biliary Cholangitis
John Vierling, MD
​​
3:35 PM - 4:00 PM
Diagnosis and Management of Hereditary Alpha-1 Antitrypsin (A1AT) Deficiency
Paul Kwo, MD
​​​​​
4:00 PM - 4:15 PM
Q&A / Panel Discussion
​
4:15 PM - 4:45 PM
Break and Visit Exhibits*
​​​​
4:45 PM - 5:30 PM
Cholestatic Liver Diseases: Discover a Treatment Option in PBC & Learn More About PFIC
Parvez Mantry, MD
Industry-Sponsored Event*
Sponsored by Ipsen Biopharmaceuticals
​​
5:30 PM - 7:00 PM
Reception*
​
Saturday, May 16, 2026
​
7:00 AM
Breakfast and Registration*
​
7:30 AM - 8:15 AM
Industry-Sponsored Event*
Sponsored by Eli Lilly and Co
​​​
8:15 AM – 8:45 AM
Break and Visit Exhibits*
8:45 AM - 8:50 AM
Program Overview
​
Session III
8:50 AM - 9:20 AM
What We Don’t Know About Celiac Disease
Lawrence Schiller, MD
9:20 AM - 9:50 AM
Endoscopic Challenges with GLP-1 Agonists
Harish Gagneja, MD
9:50 AM - 10:20 AM
Latest Updates in Irritable Bowel Syndrome (IBS)
Brooks Cash, MD
​​
​10:20 AM - 10:45 AM
Q&A / Panel Discussion
10:45 AM - 11:00 AM
Break and Visit Exhibits*
11:00 AM - 12:00 PM
Parallel Session (Select One)
-
GI Woes from Head to Toe
-
Inflammatory Bowel Disease
-
Obesity and Steatosis
-
Chronic Liver Disease
12:00 PM - 12:15 PM
Lunch and Visit Exhibits*
​
12:15 PM - 1:00 PM
Rezdiffra: Unlocking The Potential of a Liver-Directed Treatment
Reed Hogan II, MD
Industry-Sponsored Event*
Sponsored by Madrigal Pharmaceuticals
​
1:00 PM - 1:30 PM
Break and Visit Exhibits*
​
Session IV
1:30 PM - 2:00 PM
NITs for Risk Stratification in Steatotic Liver Disease
Lisa VanWagner, MD
​​
2:00 PM - 2:30 PM
New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Mack Mitchell, MD
​
2:30 PM - 2:55 PM
Management of Complications of Portal Hypertension Including Hepatic Encephalopathy and Ascites
Kimberly Brown, MD
​
2:55 PM - 3:20 PM
Screening and Management of Hepatocellular Carcinoma
Sumeet Asrani, MD
3:20 PM - 3:35 PM
Q&A / Panel Discussion
3:35 PM - 3:45 PM
Break and Visit Exhibits*
Session V
3:45 PM - 4:15 PM
Positioning Therapies in Inflammatory Bowel Disease (IBD)
David Rubin, MD​
​
4:15 PM - 4:45 PM
Managing the Pregnant Patient with IBD
Siobhan Proksell, MD
4:45 PM - 5:15 PM
Preventative Care in IBD
Freddy Caldera, MD
5:15 PM - 5:30 PM
Q&A / Panel Discussion
5:30 PM - 5:40 PM
Meeting Wrap-up




